CDH, CMG-SDIC fund co-lead $62m Series C round in Virogin Biotech

CDH, CMG-SDIC fund co-lead $62m Series C round in Virogin Biotech

Photo: Pixabay

Vancouver-based Chinese biotechnology firm Virogin Biotech has pocketed $62 million in a Series C round co-led by Chinese alternative management firm CDH Investments and CMG-SDIC Fund, a joint fund of state-owned SDIC Fund Management and China Merchants Capital.

The round also saw participation from Seoul-based Korea Investment Partners (KIP), healthcare-focused Panlin Capital, Linden Asset, Xiaoxi Holdings, and Peking University Alumni (Canada), CDH announced on Monday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter